advertisement
9.4.5.1 Neovascular glaucoma (19)
Showing records 1 to 19
Display all abstracts in classification 9.4.5.1 Neovascular glaucoma
Search within classification 9.4.5.1 Neovascular glaucoma79776 Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
Sakamoto M
Clinical Ophthalmology 2018; 12: 2323-2329
79690 Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes
Suda M
Clinical Ophthalmology 2018; 12: 2439-2449
79677 Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese - a pilot study
Choy BNK
Clinical Ophthalmology 2018; 12: 2545-2552
79913 Uncontrolled neovascular glaucoma - an alarming manifestation of chronic myeloid leukemia on imatinib therapy - a case report and review of literature
Roop P
Indian Journal of Ophthalmology 2019; 67: 285-287
80063 Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma
Simsek T
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 799-804
79677 Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese - a pilot study
Lai JSM
Clinical Ophthalmology 2018; 12: 2545-2552
79913 Uncontrolled neovascular glaucoma - an alarming manifestation of chronic myeloid leukemia on imatinib therapy - a case report and review of literature
Angmo D
Indian Journal of Ophthalmology 2019; 67: 285-287
80063 Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma
Bilgeç MD
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 799-804
79776 Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
Hashimoto R
Clinical Ophthalmology 2018; 12: 2323-2329
79690 Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes
Nakanishi H
Clinical Ophthalmology 2018; 12: 2439-2449
79913 Uncontrolled neovascular glaucoma - an alarming manifestation of chronic myeloid leukemia on imatinib therapy - a case report and review of literature
Kamble N
Indian Journal of Ophthalmology 2019; 67: 285-287
79690 Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes
Akagi T
Clinical Ophthalmology 2018; 12: 2439-2449
79776 Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
Yoshida I
Clinical Ophthalmology 2018; 12: 2323-2329
79677 Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese - a pilot study
Yeung JCC; Chan JCH
Clinical Ophthalmology 2018; 12: 2545-2552
79776 Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
Ubuka M
Clinical Ophthalmology 2018; 12: 2323-2329
79913 Uncontrolled neovascular glaucoma - an alarming manifestation of chronic myeloid leukemia on imatinib therapy - a case report and review of literature
Tomar AS; Tomar AS
Indian Journal of Ophthalmology 2019; 67: 285-287
79690 Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes
Murakami T
Clinical Ophthalmology 2018; 12: 2439-2449
79776 Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
Maeno T
Clinical Ophthalmology 2018; 12: 2323-2329
79690 Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes
Suzuma K; Suda K; Kameda T; Morooka S; Ikeda HO; Tsujikawa A
Clinical Ophthalmology 2018; 12: 2439-2449
